Unlocking the Potential of C9orf64: A Drug Target and Biomarker

Target Name: C9orf64

NCBI ID: G84267

C9orf64

Unlocking the Potential of C9orf64: A Drug Target and Biomarker

C9orf64 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biology make it an attractive target for researchers to investigate, and its potential as a drug may attract companies to invest in its development. In this article, we will explore the science behind C9orf64, its potential as a drug target, and its potential as a biomarker for various diseases.

The Discovery of C9orf64

C9orf64 was first identified in 2013 by researchers at the Broad Institute of MIT and Harvard, as a non-coding RNA molecule that showed promising properties as a drug target and biomarker. The molecule is named after its unique structure, which is similar to that of a protein known as CFP, which is involved in the regulation of gene expression.

The C9orf64 molecule is made up of 64 base pairs of RNA and has a unique feature known as a \"double-stranded loop,\" which is present in many proteins. This loop is thought to play a role in the regulation of gene expression and could be a potential drug target. The molecule also has a distinct advantage over other RNA molecules, as it is highly stable and has a low risk of degradation, which are important characteristics for a drug target.

The Potential of C9orf64 as a Drug Target

C9orf64's unique structure and biology make it an attractive target for drug development. The double-stranded loop mentioned earlier is a potential target for small molecules, which can bind to the loop and alter its stability or activity. This could lead to the inhibition of gene expression, which could be a potential mechanism of action for a drug.

Another potential mechanism of action for C9orf64 is its role in the regulation of cellular processes, such as cell division and apoptosis. The molecule has been shown to be involved in the regulation of the expression of genes involved in cell growth and differentiation, as well as the regulation of cell death. This suggests that C9orf64 could be a potential target for drugs that are aimed at preventing or treating processes that are associated with cellular dysfunction, such as cancer.

The Potential of C9orf64 as a Biomarker

C9orf64 has also been shown to have potential as a biomarker for various diseases, including cancer. The molecule has been shown to be expressed in a variety of tissues and has been used as a biomarker for cancer diagnosis and treatment.

One of the most promising applications of C9orf64 as a biomarker is its potential to serve as a target for cancer therapies. Cancer therapies often target specific molecules in order to inhibit their function and slow down or stop the growth of cancer cells. C9orf64 has been shown to be involved in the regulation of cellular processes that are associated with cancer growth, such as cell division and angiogenesis. This suggests that C9orf64 could be a potential target for cancer therapies that are aimed at inhibiting these processes.

Another application of C9orf64 as a biomarker is its potential to serve as a target for diseases that are characterized by inflammation. The molecule has been shown to be involved in the regulation of inflammatory processes, and has been used as a biomarker for diseases that are associated with inflammation, such as rheumatoid arthritis and multiple sclerosis.

The Future of C9orf64

The potential of C9orf64 as a drug target and biomarker is its main reason for its significance. The molecule's unique structure and biology make it an attractive target for research, and its potential as a drug or biomarker could attract

Protein Name: Chromosome 9 Open Reading Frame 64

Functions: Function as a queuosine-5'-monophosphate hydrolase essential for salvage of the nucleobase queuine from exogenous queuosine, following its phosphorylation by a cellular kinase (PubMed:36610787). Involved in salvaging queuosine (PubMed:15164053, PubMed:36610787)

The "C9orf64 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C9orf64 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets